Platelet Aggregation Inhibitors

"Platelet Aggregation Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Descriptor ID	D010975
MeSH Number(s)	D27.505.954.502.780
Concept/Terms	Platelet Aggregation Inhibitors Platelet Aggregation Inhibitors Aggregation Inhibitors, Platelet Inhibitors, Platelet Aggregation Blood Platelet Antiaggregants Antiaggregants, Blood Platelet Platelet Antiaggregants Antiaggregants, Platelet Blood Platelet Aggregation Inhibitors Platelet Inhibitors Platelet Inhibitors Inhibitors, Platelet Antiplatelet Agents Antiplatelet Agents Agents, Antiplatelet Antiplatelet Drugs Drugs, Antiplatelet Platelet Antagonists Platelet Antagonists Antagonists, Platelet Blood Platelet Antagonists Antagonists, Blood Platelet

Below are MeSH descriptors whose meaning is more general than "Platelet Aggregation Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Hematologic Agents [D27.505.954.502]
Platelet Aggregation Inhibitors [D27.505.954.502.780]

Below are MeSH descriptors whose meaning is related to "Platelet Aggregation Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Platelet Aggregation Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Platelet Aggregation Inhibitors" by people in this website by year, and whether "Platelet Aggregation Inhibitors" was a major or minor topic of these publications.

Bar chart showing 276 publications over 30 distinct years, with a maximum of 19 publications in 2018 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	4	6
1997	3	0	3
1998	1	4	5
1999	7	1	8
2000	5	3	8
2001	2	3	5
2002	3	0	3
2003	4	2	6
2004	8	4	12
2005	5	0	5
2006	5	1	6
2007	2	3	5
2008	7	6	13
2009	3	6	9
2010	3	5	8
2011	6	4	10
2012	6	4	10
2013	9	3	12
2014	7	7	14
2015	5	4	9
2016	8	6	14
2017	14	4	18
2018	10	9	19
2019	11	8	19
2020	5	9	14
2021	5	5	10
2022	0	7	7
2023	3	2	5
2024	4	7	11
2025	2	0	2

Below are the most recent publications written about "Platelet Aggregation Inhibitors" by people in Profiles.

Ibrahim A, Shalabi L, Zreigh S, Ramadan S, Mourad S, Eljadid G, Beshr M, Abdelaziz A, Elhadi M, Sabouret P, Mamas M. Comparative Efficacy and Safety of Low-Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv. 2025 05; 105(6):1311-1319.

View in: PubMed
Salim HA, Yedavalli V, Milhem F, Musmar B, Adeeb N, Daraghma M, El Naamani K, Henninger N, Sundararajan SH, K?hn AL, Khalife J, Ghozy S, Scarcia L, Tan BY, Regenhardt RW, Heit JJ, Cancelliere NM, Bernstock JD, Rouchaud A, Fiehler J, Sheth S, Puri AS, Dyzmann C, Colasurdo M, Renieri L, Filipe JP, Harker P, Radu RA, Abdalkader M, Klein P, Marotta TR, Spears J, Ota T, Mowla A, Jabbour P, Biswas A, Claren?on F, Siegler JE, Nguyen TN, Varela R, Baker A, Essibayi MA, Altschul D, Gonzalez NR, M?hlenbruch MA, Costalat V, Gory B, Stracke CP, Hecker C, Shaikh H, Griessenauer CJ, Liebeskind DS, Pedicelli A, Alexandre AM, Tancredi I, Faizy TD, Kalsoum E, Wintermark M, Lubicz B, Patel AB, Pereira VM, Guenego A, Dmytriw AA. Efficacy and safety of mechanical thrombectomy in distal medium middle cerebral artery occlusion ischemic stroke patients on low-dose aspirin. Int J Stroke. 2025 07; 20(6):669-678.

View in: PubMed
Dmytriw AA, Musmar B, Salim H, Aslan A, Cancelliere NM, McLellan RM, Algin O, Ghozy S, Dibas M, Lay SV, Guenego A, Renieri L, Carnevale JA, Saliou G, Mastorakos P, El Naamani K, Shotar E, Premat K, M?hlenbruch MA, Kral M, Doron O, Chung C, Salem MM, Lylyk I, Foreman PM, Vachhani JA, Shaikh H, ?upancic V, Hafeez MU, Catapano JS, Waqas M, Tutino VM, Ibrahim MK, Mohammed MA, Imamoglu C, Bayrak A, Rabinov JD, Ren Y, Schirmer CM, Piano M, Kuhn AL, Michelozzi C, Elens S, Hasan Z, Starke RM, Hassan AE, Ogilvie M, Nguyen A, Jones J, Brinjikji W, Nawka MT, Psychogios MN, Ulfert C, Diestro JDB, Pukenas B, Burkhardt JK, Huynh TJ, Martinez-Gutierrez JC, Essibayi MA, Sheth SA, Spiegel G, Tawk R, Lubicz B, Panni P, Puri AS, Pero G, Nossek E, Raz E, Killer-Oberpfalzer M, Griessenauer CJ, Asadi H, Siddiqui AH, Brook AL, Altschul D, Ducruet AF, Albuquerque FC, Regenhardt RW, Stapleton CJ, Kan P, Kalousek V, Lylyk P, Boddu SR, Knopman J, Aziz-Sultan MA, Tjoumakaris SI, Claren?on F, Limbucci N, Cuellar HH, Jabbour PM, Pereira VM, Patel AB, Adeeb N. The impact of postoperative aspirin in patients undergoing Woven EndoBridge: a multicenter, institutional, propensity score-matched analysis. J Neurointerv Surg. 2024 Dec 26; 17(e1):e15-e24.

View in: PubMed
Jason MJ, Marzec LN, Piccini JP, Shrader P, Pieper KS, Blanco RG, Fonarow GC, Gersh BJ, Ho PM, Hylek E, Kowey PR, Mahaffey KW, Steinberg BA, Peterson ED, Allen LA. Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Int J Cardiol. 2025 02 15; 421:132912.

View in: PubMed
Mandloi S, Nunes K, Sina EM, Benedict PA, Kahn C, Duffy A, Shing SR, Urdang ZD, Rosen M, Toskala E, Rabinowitz MR, Nyquist GG. Epistaxis Risk in Patients Treated With Left Atrial Appendage Occlusion Versus Oral Anticoagulation. Laryngoscope. 2025 05; 135(5):1636-1641.

View in: PubMed
Ullah W, Sandhyavenu H, Taha A, Narayana Gowda S, Mukhtar M, Reddy Polam A, Zahid S, Fischman DL, Savage MP, Rao SV, Alkhouli M. Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A?Systematic Review and Network Meta-Analysis. J Am Heart Assoc. 2024 10 15; 13(20):e032490.

View in: PubMed
Dafaalla M, Costa F, Kontopantelis E, Araya M, Kinnaird T, Micari A, Jia H, Mintz GS, Mamas MA. Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score. Eur Heart J. 2024 09 07; 45(34):3138-3148.

View in: PubMed
Plusch KJ, Miller C, Wood K, Alfonsi S, Kachooei AR, Matzon JL, Ilyas AM. The Effect of Anticoagulant and Antiplatelet Medications on Wide-Awake Hand Surgery: An Analysis of 2,162 Cases. J Hand Surg Am. 2024 10; 49(10):966-970.

View in: PubMed
Trager MH, Gordon ER, Humphreys TR, Samie FH. Part 1: Management of antithrombotic medications in dermatologic surgery. J Am Acad Dermatol. 2025 03; 92(3):389-404.

View in: PubMed
Mohamed MO, Kontopantelis E, Alasnag M, Abid L, Banerjee A, Sharp ASP, Bourantas C, Sirker A, Curzen N, Mamas MA. Impact of Society Guidelines on Trends in Use of Newer P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2024 05 07; 13(9):e034414.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement